Tafas v. Kappos
U.S. Court of Appeals for the Federal Circuit
Tafas v. Kappos, 332 F. App'x 635 (Fed. Cir. 2009)
Tafas v. Kappos
Opinion of the Court
ORDER
Upon consideration of the court’s July 28, 2009, 831 Fed.Appx. 748, order granting the parties’ joint motion for a stay of en banc proceedings,
IT IS ORDERED THAT:
Absent further order of this court, the appellants’ additional en banc brief is due within 60 days of the date of filing of this order. Absent further order of this court, the parties shall file the required copies of their original briefs within 60 days of the date of filing of this order. The remaining brief due dates should be calculated in compliance with this court’s July 6, 2009, 328 Fed.Appx. 658, order.
Reference
- Full Case Name
- Triantafyllos TAFAS, and SmithKline Beecham Corporation (doing business as GlaxoSmithKline), SmithKline Beecham PLC, and Glaxo Group Limited (doing business as GlaxoSmithKline) v. David J. KAPPOS, Under Secretary of Commerce for Intellectual Property and Director of the United States Patent and Trademark Office, and United States Patent and Trademark Office
- Status
- Published